Get to “Nose”: Part 2 – Individualizing Treatment for Chronic Rhinosinusitis with Nasal Polyps: Novel Options for Optimizing Outcomes – Clinical Review

Target Audience

Physician specialists (allergists, immunologists, ENTs) and primary care providers who may treat patients with CRSwNP.

Program Overview

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic condition associated with multiple comorbidities and decreased quality of life. It is a condition characterized by inflammation of the sinonasal mucosa and clinical symptoms including blocked nose, rhinorrhea, hyposmia or anosmia, and pain or pressure in the face. Advances in understanding of the underlying pathology for CRSwNP has resulted in novel immunomodulatory biologic therapies for its treatment.

In the second of a 2-part series, this text-based activity will offer learners an in-depth review of the clinical data with biologic therapies for the treatment of CRSwNP.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Evaluate the mechanism of action, safety, and efficacy of biologics for the treatment of chronic rhinosinusitis with nasal polyps